Monographie - Omeprazole sodium

Viimeisin päivitys :
08/05/2024

Omeprazole sodium

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Antra	Italia, Saksa, Sveitsi
Biomezol	Ecuador
Cezole	Marokko
Ciplaprazole	Kolumbia
Dinsadrix	Meksiko
Fendiprazole	Argentiina
Finulcer	Meksiko
Fordex	Venezuela
Gaspiren	Brasilia
Gastromax	Venezuela
Gerdex	Meksiko
Haitrax	Meksiko
Helicid	Puola
Imaroz	Chile
Inhibitron	Meksiko
Ipproton	Saudi-Arabia, Tunisia
Klomeprax	Argentiina, Ecuador
Lordin	Kreikka
Losec	Belgia, Hollanti, Iso-Britannia, Italia, Itävalta, Puola, Saudi-Arabia, Turkki
Mepral	Italia
Omeprazen	Italia
Omeprazol	Saksa
Omeprazole	Ranska
Oprazole	Saudi-Arabia
Penrazol	Kreikka
Rizek	Saudi-Arabia
Timezol	Argentiina
Ulcozol	Argentiina
Ultop	Kroatia

Viitteet : Omeprazole sodium

	Tyyppi	Julkaisu
186	Lehti	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
264	Lehti	Leboucher G, Charpiat B. Incompatibilité physico-chimique entre l’oméprazole et la vancomycine. Pharm Hosp Fr 1997 ; 121: 124.
1703	Lehti	Schuster F, Bernard R. Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln. Krankenhauspharmazie 1995 ; 16: 101-103.
2231	Lehti	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2311	Lehti	Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. J Clin Pharm Ther 2009 ; 34: 25-31.
3332	Laboratorio	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3658	Laboratorio	Omeprazole - Summary of Product Characteristics. Sandoz 2014
3823	Lehti	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3871	Ilmoitus	Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Synprefh Congress Clermont Ferrand, France 2016
3976	Lehti	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985	Ilmoitus	Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Hopipharm Congress 2017 - Nancy 2017
4316	Lehti	Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F. Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion. J Pharm Technol 2006 ;22:95-98.
4642	Ilmoitus	Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 2021

Mentions Légales